


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:52:24Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12404870" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12404870</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>orthopsurg</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" id="os70149" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Orthop Surg</journal-id><journal-id journal-id-type="iso-abbrev">Orthop Surg</journal-id><journal-id journal-id-type="pmc-domain-id">3643</journal-id><journal-id journal-id-type="pmc-domain">orthopsurg</journal-id><journal-id journal-id-type="publisher-id">OS</journal-id><journal-title-group><journal-title>Orthopaedic Surgery</journal-title></journal-title-group><issn pub-type="ppub">1757-7853</issn><issn pub-type="epub">1757-7861</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12404870</article-id><article-id pub-id-type="pmcid-ver">PMC12404870.1</article-id><article-id pub-id-type="pmcaid">12404870</article-id><article-id pub-id-type="pmcaiid">12404870</article-id><article-id pub-id-type="pmid">40787768</article-id><article-id pub-id-type="doi">10.1111/os.70149</article-id><article-id pub-id-type="publisher-id">OS70149</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A New Nanotechnology for Imaging the Juxta&#8208;Articular Intraosseous Vasculature&#8208;Canal Complex and Related Clinical Pilot Studies</article-title></title-group><contrib-group><contrib id="os70149-cr-0001" contrib-type="author"><name name-style="western"><surname>Dou</surname><given-names initials="M">Mengmeng</given-names></name><xref rid="os70149-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="os70149-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="os70149-cr-0002" contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="J">Jinfeng</given-names></name><xref rid="os70149-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="os70149-cr-0003" contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="J">Jiaoran</given-names></name><xref rid="os70149-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="os70149-cr-0004" contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="J">Jianmin</given-names></name><xref rid="os70149-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="os70149-cr-0005" contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Z">Zhenzhong</given-names></name><xref rid="os70149-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="os70149-cr-0006" contrib-type="author" corresp="yes"><name name-style="western"><surname>Shao</surname><given-names initials="X">Xianhao</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6044-9959</contrib-id><xref rid="os70149-aff-0007" ref-type="aff">
<sup>7</sup>
</xref><address><email>sxhleo@163.com</email></address></contrib><contrib id="os70149-cr-0007" contrib-type="author" corresp="yes"><name name-style="western"><surname>Su</surname><given-names initials="X">Xia</given-names></name><xref rid="os70149-aff-0008" ref-type="aff">
<sup>8</sup>
</xref><address><email>1064735798@qq.com</email></address></contrib><contrib id="os70149-cr-0008" contrib-type="author" corresp="yes"><name name-style="western"><surname>Li</surname><given-names initials="J">Jing</given-names></name><xref rid="os70149-aff-0009" ref-type="aff">
<sup>9</sup>
</xref><address><email>qlyylj@126.com</email></address></contrib><contrib id="os70149-cr-0009" contrib-type="author" corresp="yes"><name name-style="western"><surname>Wang</surname><given-names initials="G">Guanghui</given-names></name><xref rid="os70149-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>wang_sd37@qq.com</email><email>wang_sd37@163.com</email></address></contrib><contrib id="os70149-cr-0010" contrib-type="author" corresp="yes"><name name-style="western"><surname>Cheng</surname><given-names initials="K">Kun</given-names></name><xref rid="os70149-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>chengkun_ql@163.com</email></address></contrib></contrib-group><aff id="os70149-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>Tianjin First Central Hospital</institution>
<city>Tianjin</city>
<country country="CN">China</country>
</aff><aff id="os70149-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Orthopaedics</named-content>
<institution>Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University</institution>
<city>Qingdao</city>
<country country="CN">China</country>
</aff><aff id="os70149-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Equipment and Materials</named-content>
<institution>Tianjin First Central Hospital</institution>
<city>Tianjin</city>
<country country="CN">China</country>
</aff><aff id="os70149-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Anatomy and Neurobiology</named-content>
<institution>School of Basic Medical Sciences, Shandong University</institution>
<city>Jinan</city>
<named-content content-type="country-part">Shandong</named-content>
<country country="CN">China</country>
</aff><aff id="os70149-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Orthopaedics</named-content>
<institution>Qilu Hospital, Cheeloo College of Medicine, Shandong University</institution>
<city>Jinan</city>
<country country="CN">China</country>
</aff><aff id="os70149-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Department of Anatomy and Neurobiology</named-content>
<institution>Cheeloo College of Medicine, Shandong University</institution>
<city>Jinan</city>
<country country="CN">China</country>
</aff><aff id="os70149-aff-0007">
<label>
<sup>7</sup>
</label>
<named-content content-type="organisation-division">Department of Orthopaedics</named-content>
<institution>Shandong Provincial Hospital Affiliated to Shandong First Medical University</institution>
<city>Jinan</city>
<named-content content-type="country-part">Shandong</named-content>
<country country="CN">China</country>
</aff><aff id="os70149-aff-0008">
<label>
<sup>8</sup>
</label>
<named-content content-type="organisation-division">Department of PICC Clinic</named-content>
<institution>Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University</institution>
<city>Qingdao</city>
<country country="CN">China</country>
</aff><aff id="os70149-aff-0009">
<label>
<sup>9</sup>
</label>
<named-content content-type="organisation-division">Department of Pediatric Internal Medicine</named-content>
<institution>Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University</institution>
<city>Qingdao</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence:</bold><break/>
Xianhao Shao (<email>sxhleo@163.com</email>)<break/>
Xia Su (<email>1064735798@qq.com</email>)<break/>
Jing Li (<email>qlyylj@126.com</email>)<break/>
Guanghui Wang (<email>wang_sd37@qq.com</email>; <email>wang_sd37@163.com</email>)<break/>
Kun Cheng (<email>chengkun_ql@163.com</email>)<break/></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>17</volume><issue seq="260">9</issue><issue-id pub-id-type="pmc-issue-id">496083</issue-id><issue-id pub-id-type="doi">10.1111/os.v17.9</issue-id><fpage>2744</fpage><lpage>2755</lpage><history><date date-type="rev-recd"><day>23</day><month>7</month><year>2025</year></date><date date-type="received"><day>21</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>27</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>11</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">Orthopaedic Surgery</italic> published by Tianjin Hospital and John Wiley &amp; Sons Australia, Ltd.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="OS-17-2744.pdf"/><self-uri content-type="pdf" xlink:href="file:OS-17-2744.pdf"/><abstract><title>ABSTRACT</title><sec id="os70149-sec-0001"><title>Objective</title><p>The objective of this study is to achieve distinct visualization of juxta&#8208;articular intraosseous microvessels, a novel nanoimaging methodology in which superparamagnetic iron oxide nanoparticles and meglumine diatrizoate (MD) are used cooperatively was implemented.</p></sec><sec id="os70149-sec-0002"><title>Methods</title><p>A newly created composite of MD and Fe<sub>3</sub>O<sub>4</sub> nanoparticles (MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs) was prepared as a contrast agent to achieve efficacious imaging of the juxta&#8208;articular intraosseous vasculature&#8208;canal complex (JIVCC). Scanning electron microscopy (SEM) and energy dispersive spectrum (EDS) were employed to observe the structural characteristics and binding stability of the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs. In 20 rabbits that received an injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs, 1&#8208;mm&#8208;thick computed tomography (CT) scanning was performed for radiographic assessment. Hematoxylin&#8211;eosin&#8208; and potassium ferrocyanide&#8208;stained sections from 10 sacrificed rabbits were used to observe the histological characteristics of JIVCC with MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs, and the remaining 10 rabbits were utilized for a systemic safety evaluation. After a healthy volunteer received an MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP injection, we also performed CT scanning and related safety evaluations.</p></sec><sec id="os70149-sec-0003"><title>Results</title><p>When the MD nanoparticles and amino&#8208;Fe<sub>3</sub>O<sub>4</sub> nanoparticles were mixed together, they aggregated into a stable compound structure according to microscopic observations and SEM&#8211;EDS verification. In 20 rabbits&#160;receiving&#160;MD&#8208;Fe<sub>3</sub>O<sub>4</sub> injections, 1&#8208;mm slice CT imaging demonstrated significantly enhanced visualization of the JIVCCs in magnet&#8208;placed knees compared to contralateral limbs (tibial JIVCC: <italic toggle="no">p</italic>&#8201;&lt;&#8201;0.001; femoral JIVCC: <italic toggle="no">p</italic>&#8201;&lt;&#8201;0.001), confirming MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs as the efficacious magnetic contrast enhancer. The histological characteristics of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs in JIVCC were revealed. The levels of serum iron before and 4 and 72&#8201;h after MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP injection were 23.9&#8201;&#177;&#8201;2.13&#8201;&#956;mol/L, 26.2&#8201;&#177;&#8201;2.30&#8201;&#956;mol/L, and 24.9&#8201;&#177;&#8201;2.33&#8201;&#956;mol/L, respectively, indicating that there was no significant difference in safety (<italic toggle="no">p</italic>&#8201;=&#8201;0.092). After a volunteer received MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs via intravenous administration, the JIVCC was clearly visualized, laboratory tests of serum iron levels were normal, and no injection&#8208;related complications occurred.</p></sec><sec id="os70149-sec-0004"><title>Conclusions</title><p>A novel compound nanoparticle, which achieved satisfactory overall outcomes, was implemented as an appropriate alternative for the discernible visualization of juxta&#8208;articular intraosseous microvessels. The nanotechnology utilized in this study may augment the clinical imaging methodology for the osseous vascular system.</p></sec></abstract><abstract abstract-type="graphical"><p>The schematic diagram of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs application. MD&#8208;Fe<sub>3</sub>O<sub>4</sub> nanoparticle is efficacious to realize the visualization of juxta&#8208;articular intraosseous microvessels. The application of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> nanoparticle can serve as a warranted clinical imaging method.<boxed-text position="anchor" content-type="graphic" id="os70149-blkfxd-0001" orientation="portrait"><graphic position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="OS-17-2744-g002.jpg"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="os70149-kwd-0001">imaging</kwd><kwd id="os70149-kwd-0002">intraosseous vasculature</kwd><kwd id="os70149-kwd-0003">meglumine diatrizoate</kwd><kwd id="os70149-kwd-0004">nanotechnology</kwd><kwd id="os70149-kwd-0005">superparamagnetic iron oxide</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>the Natural Science Foundation of Shandong Province</institution></institution-wrap></funding-source><award-id>ZR2023QH465</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Qingdao Clinical Key Specialty</institution></institution-wrap></funding-source><award-id>QDZDZK&#8208;2022095</award-id></award-group></funding-group><counts><fig-count count="7"/><table-count count="1"/><page-count count="12"/><word-count count="7800"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.2 mode:remove_FC converted:02.09.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="os70149-cit-1001"><string-name name-style="western"><given-names>M.</given-names><surname>Dou</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Yang</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Li</surname></string-name>, et al., &#8220;<article-title>A New Nanotechnology for Imaging the Juxta&#8208;Articular Intraosseous Vasculature&#8208;Canal Complex and Related Clinical Pilot Studies</article-title>,&#8221; <source>Orthopaedic Surgery</source><volume>17</volume>, no. <issue>9</issue> (<year>2025</year>): <fpage>2744</fpage>&#8211;<lpage>2755</lpage>, <pub-id pub-id-type="doi">10.1111/os.70149</pub-id>.<pub-id pub-id-type="pmcid">PMC12404870</pub-id><pub-id pub-id-type="pmid">40787768</pub-id></mixed-citation>
</p><fn-group id="os70149-ntgp-0001"><fn fn-type="funding" id="os70149-note-0001"><p>
<bold>Funding:</bold> This work was supported by the Natural Science Foundation of Shandong Province (Grant No. ZR2023QH465) and Qingdao Clinical Key Specialty (Grant No. QDZDZK&#8208;2022095).</p></fn><fn fn-type="equal" id="os70149-note-0002"><p>Kun Cheng, Guanghui Wang, Jing Li, Xia Su, and Xianhao Shao contributed equally to this work and are joint corresponding authors.</p></fn></fn-group></notes></front><body id="os70149-body-0001"><def-list list-content="abbreviations" id="os70149-dl-0001"><title>Abbreviations</title><def-item><term id="os70149-li-0001">CT</term><def id="os70149-li-0002"><p>Computed tomography</p></def></def-item><def-item><term id="os70149-li-0003">HE</term><def id="os70149-li-0004"><p>hematoxylin&#8211;eosin</p></def></def-item><def-item><term id="os70149-li-0005">JIVCC</term><def id="os70149-li-0007"><p>juxta&#8208;articular intraosseous vasculature&#8208;canal complex</p></def></def-item><def-item><term id="os70149-li-0008">LSFM</term><def id="os70149-li-0009"><p>light sheet fluorescence microscope</p></def></def-item><def-item><term id="os70149-li-0010">MD</term><def id="os70149-li-0011"><p>meglumine diatrizoate</p></def></def-item><def-item><term id="os70149-li-0012">MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs</term><def id="os70149-li-0013"><p>meglumine diatrizoate and Fe<sub>3</sub>O<sub>4</sub> nanoparticles</p></def></def-item><def-item><term id="os70149-li-0014">MRI</term><def id="os70149-li-0015"><p>magnetic resonance imaging</p></def></def-item><def-item><term id="os70149-li-0016">SEM</term><def id="os70149-li-0017"><p>scanning electron microscopy</p></def></def-item><def-item><term id="os70149-li-0018">SEM&#8211;EDS</term><def id="os70149-li-0019"><p>scanning electron microscopy and energy dispersive spectrum</p></def></def-item><def-item><term id="os70149-li-0020">SPIONs</term><def id="os70149-li-0021"><p>superparamagnetic iron oxide nanoparticles</p></def></def-item><def-item><term id="os70149-li-0022">TCVs</term><def id="os70149-li-0023"><p>trans&#8208;cortical vessels</p></def></def-item><def-item><term id="os70149-li-0024">UHF</term><def id="os70149-li-0025"><p>ultrahigh field</p></def></def-item></def-list><sec id="os70149-sec-0005"><label>1</label><title>Introduction</title><p>The long bones perform considerable physiological functions in the musculoskeletal system, such as weight bearing, motion, and inorganic salt metabolism, in which the intraosseous vasculatures play a vital role [<xref rid="os70149-bib-0001" ref-type="bibr">1</xref>, <xref rid="os70149-bib-0002" ref-type="bibr">2</xref>]. In 2019, Gr&#252;neboom et&#160;al. explored a network of trans&#8208;cortical vessels (TCVs), which significantly advanced the understanding of the cortical vasculature, and their data indicated that TCVs are a central component of the cortical circulatory system in long bones with important physiological functions and clinical value [<xref rid="os70149-bib-0003" ref-type="bibr">3</xref>, <xref rid="os70149-bib-0004" ref-type="bibr">4</xref>]. However, new anatomical discoveries of the juxta&#8208;articular intraosseous vasculature system have been rare in recent decades [<xref rid="os70149-bib-0005" ref-type="bibr">5</xref>, <xref rid="os70149-bib-0006" ref-type="bibr">6</xref>], and the paucity of efficient specific imaging technology for such structures is an important constraint.</p><p>Currently, several challenges exist in in&#160;vivo imaging technology for microvessels in human bones, taking into account both exact visualization and potential large&#8208;scale clinical application. Currently, bone scintigraphy and laser scanning are preliminarily applied for tracking intraosseous vessels. However, volunteers have to suffer several hours for continuous tracking and postprocessing when undertaking such methodologies, which are uncertainly regarded as facile clinical routines in the future [<xref rid="os70149-bib-0004" ref-type="bibr">4</xref>, <xref rid="os70149-bib-0007" ref-type="bibr">7</xref>]. Fluorescence microscopy, which is an imaging method that can be used to observe osseous capillaries and examine their hemodynamic features, is also not an appropriate choice for routine clinical work because of its high cost [<xref rid="os70149-bib-0003" ref-type="bibr">3</xref>, <xref rid="os70149-bib-0008" ref-type="bibr">8</xref>]. Magnetic resonance imaging with high field and spatial resolution may currently contribute to the recognition of trans&#8208;cortical and intraosseous vasculatures, but this radiographic technique often results in inevitable discontinuities in tiny blood vessels [<xref rid="os70149-bib-0009" ref-type="bibr">9</xref>, <xref rid="os70149-bib-0010" ref-type="bibr">10</xref>]. Moreover, these methods are utilized to scan diaphyseal vessels rather than juxta&#8208;articular intraosseous microvessels. In recent years, some scholars have attempted to use submillimeter&#8208;resolution steady&#8208;state magnetic resonance angiography to detect small arteries in the femoral head in&#160;vivo. Intraosseous vascular fragments can be observed, but sagittal and coronal reconstruction images of these vessels often lose their continuity, and such angiography is performed only for the small arteries in the proximal femoral region [<xref rid="os70149-bib-0011" ref-type="bibr">11</xref>]. MicroCT, the preeminent imaging technology for bony microarchitecture, also seems impractical for visualizing juxta&#8208;articular intraosseous soft tissues [<xref rid="os70149-bib-0012" ref-type="bibr">12</xref>].</p><p>Intraosseous and transosseous vessels in the epiphyseal and metaphyseal regions play important roles in diverse orthopedic diseases (e.g., ischemic osteonecrosis, articular cartilage degeneration, bone neoplasm, osseous tuberculosis) [<xref rid="os70149-bib-0013" ref-type="bibr">13</xref>, <xref rid="os70149-bib-0014" ref-type="bibr">14</xref>, <xref rid="os70149-bib-0015" ref-type="bibr">15</xref>, <xref rid="os70149-bib-0016" ref-type="bibr">16</xref>]. The theoretical basis of this clinical phenomenon is that these vasculatures present potential &#8220;breakpoints&#8221; on the bone cortex, cartilage, or subchondral bone plate to facilitate the dissemination of tumor cells or pathogens between the intraosseous and extraosseous compartments. Specifically, the existence of these tiny vessels and their bony canals provides anatomic spaces that can conceal pathogenic factors from operative curettage or resection and facilitate lesion invasion. In our previous studies, we conducted a retrospective study to investigate the general oncological implications of juxta&#8208;articular intraosseous vessels. On this basis, we found that juxta&#8208;articular vasculature&#8208;canal complexes increase and accelerate the local recurrence and tumor dissemination of bone neoplasms in the subchondral area around the knee. In patients with lesion invasion of the subchondral vasculature&#8208;canal complex, we observed a higher recurrence rate and shorter relapse period than in those with lesions in other femoral or tibial intraosseous regions after the same surgical treatments. The occurrence of these clinical phenomena may be related to difficulty in conducting thorough tumor curettage or resection in the subchondral vasculature&#8208;canal complex via a high&#8208;speed burr and electrocautery, which are usually selected to achieve an extensively safe margin of the lesion in cancellous and cortical bone, since such an anatomic structure is easy to ignore because of its small size. Therefore, a safe and practical imaging method could benefit a wide range of patients because the distinct imaging of juxta&#8208;articular intraosseous vessels can be established for extensive clinical application. Superparamagnetic iron oxide nanoparticles (SPIONs) are magnetic responsive nanoparticles that have been widely investigated in the mechanical, electronic, optical, chemical, and biomedical fields [<xref rid="os70149-bib-0017" ref-type="bibr">17</xref>, <xref rid="os70149-bib-0018" ref-type="bibr">18</xref>, <xref rid="os70149-bib-0019" ref-type="bibr">19</xref>, <xref rid="os70149-bib-0020" ref-type="bibr">20</xref>, <xref rid="os70149-bib-0021" ref-type="bibr">21</xref>]. In previous studies, the utilization of SPIONs combined with charged drug micelles as carriers not only achieved better therapeutic effects but also guaranteed safety for clinical perfusion therapy [<xref rid="os70149-bib-0022" ref-type="bibr">22</xref>]. Therefore, in theory, orchestrated magnetic compound microparticles can enable SPIONs to carry contrast medium to implement effective and reliable imaging of epiphyseal and metaphyseal intraosseous microvessels.</p><p>This study is based on our previous discovery of the juxta&#8208;articular intraosseous vasculature&#8208;canal complex (JIVCC) (also called the LC complex in the knee joint), which has been described in the anatomic, radiographic, histologic, and surgical fields (Figure&#160;<xref rid="os70149-fig-0001" ref-type="fig">1</xref>) [<xref rid="os70149-bib-0005" ref-type="bibr">5</xref>, <xref rid="os70149-bib-0006" ref-type="bibr">6</xref>], hoping to explore an efficient imaging method for JIVCC that is suitable for clinical promotion. We plan to use amino&#8208;Fe<sub>3</sub>O<sub>4</sub> nanoparticles to adsorb meglumine diatrizoate (MD) as a contrast medium and create a novel composite of MD and Fe<sub>3</sub>O<sub>4</sub> nanoparticles (MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs) to achieve the imaging of JIVCC in&#160;vivo. This investigation aims to (I) explore the characteristics of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs that are suitable for JIVCC nanoimaging; (II) investigate the chemical, radiographical, and histological features of this nanoimaging technology and verify its rationality and safety; (III) elucidate the clinical feasibility and potential clinical significance of this new imaging method.</p><fig position="float" fig-type="FIGURE" id="os70149-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Schematic figure for the anatomic and microarchitectural features of juxta&#8208;articular intraosseous vasculature&#8208;canal complex (JIVCC). (A) The gross anatomical dissection showing a femoral JIVCC arteriole (empty arrowhead) originated from the branches of middle genicular artery (empty arrow), and a femoral and a tibial JIVCC venules (arrowheads) originated from the tributaries of the middle genicular vein (arrow). (B) Bony canal of a femoral JIVCC (dashed line) shown on reconstructed sagittal microCT images. (C) Bony canal of a tibial JIVCC (dashed line) shown on reconstructed coronal microCT images. <named-content content-type="attribution">
<italic toggle="yes">Source</italic>: Adapted from Reference [<xref rid="os70149-bib-0005" ref-type="bibr">5</xref>]. Copyright &#169; 2021 Shao, Li, Zhang, Yao, Sun, Li, Liu, Hou, Li, Li, Gao, Yang, Li, Li and Cheng under CC BY.</named-content>
</p></caption><graphic position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="OS-17-2744-g001.jpg"/></fig></sec><sec sec-type="materials-and-methods" id="os70149-sec-0006"><label>2</label><title>Materials and Methods</title><p>This study was reviewed and approved by the Medical Ethics Committee of Shandong University (No. LL&#8208;2016&#8208;1&#8208;040). Twenty SPF New Zealand rabbits (purchased from Qingdao Kangda Biotechnology Co. Ltd., China) were used in this investigation, and a volunteer (one of the researchers of this study) received an injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs.</p><sec id="os70149-sec-0007"><label>2.1</label><title>
<styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NP</styled-content> Preparation and Electron Microscope Analysis</title><p>We purchased 20&#176;C compound MD injection (GYZZ H37023984, Lunanbeite Pharmaceutical Co. Ltd., China) and amino&#8208;Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticle dispersion agent (100&#8201;nm, 10&#8201;mL: 50&#8201;mg [Tianjin Beisile Chromatographic Technology Development Center, China]) for this research. Half of the dose of the MD and one dose of SPION solution were mixed for the injection of each experimental rabbit. When the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were prepared, an oscillator was used to oscillate at a frequency of 200 times/min for 5&#8201;min. The morphology, size, and elemental composition of the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were observed by scanning electron microscopy (SEM) (JEM&#8208;1200EXII, JEOL Ltd., Tokyo, Japan) and evaluated by SEM and energy dispersive spectrum (SEM&#8211;EDS) analytic system (JEOL Ltd., Tokyo, Japan), as were the stability of the compound particles. For SEM&#8211;EDS analysis, the well&#8208;prepared MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were mounted appropriately and subjected to microanalysis via a Bruker Nano Berlin instrument. The ultrastructures of the examined MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were analyzed at a primary energy of 10&#8201;keV. For the tested samples, maps of the distribution of elements, including O, Fe, C, N, and I, were generated.</p></sec><sec id="os70149-sec-0008"><label>2.2</label><title>
<styled-content style="fixed-case" toggle="no">CT</styled-content> Scanning of <styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NP</styled-content>&#8208;Injected Rabbits In&#160;Vivo</title><p>After general anesthesia and fixation, the unilateral lower limb of each experimental rabbit was abducted, a 50&#8201;&#215;&#8201;30&#8201;&#215;&#8201;10&#8201;mm<sup>3</sup> neodymium magnet was placed parallel to the targeted femoral or tibial JIVCC around the knee joint, and the contralateral lower extremity was also abducted for a control experiment. One&#8208;millimeter&#8208;thick computed tomography (CT) (Definition Flash, Siemens, Germany) scanning was performed, and the images were coronal, sagittal, and three&#8208;dimensional reconstructed to detect the radiographic characteristics of the JIVCC. All the imaging data were reviewed by two experienced radiologists.</p></sec><sec id="os70149-sec-0009"><label>2.3</label><title>Histological Section of <styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NP</styled-content>&#8208;Injected <styled-content style="fixed-case" toggle="no">JIVCC</styled-content>
</title><p>Ten experimental rabbits were sacrificed to harvest MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP&#8208;injected JIVCC. The obtained knee joints were frozen in a deep freezer (&#8722;86&#176;C) (DW&#8208;86L338, Qingdao Haier Company, China) and then cut in the frozen state. After being immersed in formaldehyde solution for 7&#8201;days, the samples were soaked in EDTA decalcifying solution for another 14&#8201;days for decalcification. The proximal tibia and distal femur were sectioned and stained with hematoxylin&#8211;eosin (HE) (Nanchang Yulu Experimental Equipment Co. Ltd., China) and potassium ferrocyanide (Shanghai Yuanye Bio&#8208;Technology Co. Ltd., China), and the histological characteristics of JIVCC with MD&#8208;Fe<sub>3</sub>O<sub>4</sub> nanocomposite particles were observed via an Olympus IX&#8208;70 microscope (IX&#8208;70, Tokyo, Japan).</p></sec><sec id="os70149-sec-0010"><label>2.4</label><title>Safety Testing for <styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NP</styled-content> Application</title><p>The remaining 10 rabbits were fed as usual after regaining consciousness from anesthesia, and urine volume, color, and precipitation were observed for 48&#8201;h after anesthesia. To verify whether the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were excreted, we collected urinary and enteric excreta to search for potential discharged magnetic nanoparticles under the action of a magnetic field. For a quantitative safety evaluation, the blood samples from all 10 rabbits were digested for 5&#8201;min, filtered, and diluted with deionized water. The digests were subjected to an air/acetylene fast sequential flame atomic absorption spectrophotometer (Thermo Fisher Scientific, USA) to determine the serum Fe concentration. Serum ferric levels were determined three times before the injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs, 4&#8201;h after the injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs, and 3&#8201;days after the injection.</p></sec><sec id="os70149-sec-0011"><label>2.5</label><title>Radiographic Analysis and Safety Testing for an <styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NP</styled-content>&#8208;Injected Volunteer</title><p>On the basis of the safety assessment for MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs in experimental rabbits and the sterility of the reagent, a volunteer received MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP injection and CT scanning. The MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were injected via the dorsal hand vein, and a larger N35 neodymium magnet (Shanghai Genchang Electromechanical Company, China) with a meter magnet of 850&#8201;G was closely attached to the knee joint and placed parallel to the targeted femoral or tibial JIVCC to provide a magnetic field. The 1&#8208;mm&#8208;thick CT scan of the knee joint was performed at 1&#8201;min after the injection. The JIVCCs were also observed on the coronal and sagittal reconstructed CT images. The serum ferric levels of the volunteer were determined three times: before the injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs, 4&#8201;h after the injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs, and 2&#8201;weeks after the injection [<xref rid="os70149-bib-0023" ref-type="bibr">23</xref>]. Whether related complications occurred was also recorded.</p></sec><sec id="os70149-sec-0012"><label>2.6</label><title>Statistical Analysis</title><p>SPSS 21.0 (IBM Corp., USA) was used for all the statistical calculations in this investigation. Fisher's precision probability test was performed to statistically compare the number of discernible contrasted JIVCCs before and after MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP injection. The chi&#8208;square test was applied for the statistical comparison of the histological detection rate of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs in JIVCCs between the experimental side with a magnetic field and the contralateral lower extremity. A paired <italic toggle="yes">t</italic>&#8208;test was performed to analyze significant differences in the 48&#8208;h urine volume of the experimental rabbits before and after MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP injection. The serum ferric level was analyzed via one&#8208;way ANOVA, followed by Fisher's least significant difference post hoc test for comparisons between two groups. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="os70149-sec-0013"><label>3</label><title>Results</title><sec id="os70149-sec-0014"><label>3.1</label><title>Characteristics of <styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NPs</styled-content>
</title><p>Under transmission electron microscopy, we observed that single diatrizoated meglumine particles with a diameter of 20&#8201;&#177;&#8201;2&#8201;nm presented as regular spheres and were uniformly dispersed in the solution (Figure&#160;<xref rid="os70149-fig-0002" ref-type="fig">2A</xref>). The amino&#8208;Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles with a diameter of 100&#8201;&#177;&#8201;10&#8201;nm presented as microspherical clusters and were also dispersed in solution (Figure&#160;<xref rid="os70149-fig-0002" ref-type="fig">2B</xref>). When the two types of nanoparticles are mixed together, they automatically aggregate into a stable compound structure under neutralization adsorption (Figure&#160;<xref rid="os70149-fig-0002" ref-type="fig">2C</xref>). The stable combination of MD and amino&#8208;Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles was also verified by SEM (Figure&#160;<xref rid="os70149-fig-0002" ref-type="fig">2D&#8211;F</xref>).</p><fig position="float" fig-type="FIGURE" id="os70149-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Characteristics of meglumine diatrizoate nanoparticles, amino&#8208;Fe<sub>3</sub>O<sub>4</sub> nanoparticles, and MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs under electron microscopy. (A) Regular spherical meglumine diatrizoate nanoparticles (20&#8201;&#177;&#8201;2&#8201;nm) under TEM. Scale bar, 100&#8201;nm. (B) Regular spherical amino&#8208;Fe<sub>3</sub>O<sub>4</sub> nanoparticles (100&#8201;&#177;&#8201;10&#8201;nm) under TEM. Scale bar, 200&#8201;nm. (C) MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs showing a stable combination under TEM, with no free Fe<sub>3</sub>O<sub>4</sub> or MD nanoparticles. Scale bar, 200&#8201;nm. (D) SEM image of regular spherical meglumine diatrizoate nanoparticles (20&#8201;&#177;&#8201;2&#8201;nm). Scale bar, 100&#8201;nm. (E) SEM image of regular spherical amino&#8208;Fe<sub>3</sub>O<sub>4</sub> nanoparticles (100&#8201;&#177;&#8201;10&#8201;nm). Scale bar, 100&#8201;nm. (F) SEM image of the stable combination of well&#8208;prepared MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs, which showed no free Fe<sub>3</sub>O<sub>4</sub> or MD nanoparticles. Scale bar, 100&#8201;nm.</p></caption><graphic position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="OS-17-2744-g003.jpg"/></fig><p>After the well&#8208;prepared MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were established and scanned (Figure&#160;<xref rid="os70149-fig-0003" ref-type="fig">3A</xref>), the contained elements were examined via SEM&#8211;EDS analysis (Figure&#160;<xref rid="os70149-fig-0003" ref-type="fig">3B&#8211;H</xref>). The Fe that only existed in amino&#8208;Fe<sub>3</sub>O<sub>4</sub> and I that only existed in MD were distributed in equilibrium, indicating that the MD and Fe<sub>3</sub>O<sub>4</sub> nanoparticles were uniformly combined (Figure&#160;<xref rid="os70149-fig-0003" ref-type="fig">3D,G</xref>). There was no part presenting a lopsided concentration of either only Fe<sub>3</sub>O<sub>4</sub> or only MD (Figure&#160;<xref rid="os70149-fig-0003" ref-type="fig">3H</xref>). Overall, the MD with a diameter of 20&#8201;&#177;&#8201;2&#8201;nm and the amino&#8208;Fe<sub>3</sub>O<sub>4</sub> with a diameter of 100&#8201;&#177;&#8201;10&#8201;nm are two suitable nanoparticles with satisfactory particular sizes, superparamagnetic characteristics, and aggregation forces to form the compound MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs.</p><fig position="float" fig-type="FIGURE" id="os70149-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>SEM&#8211;EDS analysis and mapping of the element distribution in the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs. (A) SEM image of well&#8208;prepared MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs. (B) Energy dispersive spectrum analysis of each element in the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs. (C&#8211;H) Maps of the distribution of each element, including O (C), Fe (D), C (E), N (F), and I (G), in the well&#8208;prepared MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs. (H) Total distribution of all the elements.</p></caption><graphic position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="OS-17-2744-g004.jpg"/></fig></sec><sec id="os70149-sec-0015"><label>3.2</label><title>Radiographic Characteristics of <styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NP</styled-content>&#8208;Injected <styled-content style="fixed-case" toggle="no">JIVCC</styled-content>
</title><p>After the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were injected into the ear vein of 20 eligible rabbits, the contrast agents were immediately concentrated in the liver and urinary system, including the kidney, ureter, and bladder. In the knee joint set with the neodymium magnet (Figure&#160;<xref rid="os70149-fig-0004" ref-type="fig">4A</xref>), clear images of JIVCCs in both the proximal tibia and distal femur were displayed under 1&#8208;mm&#8208;thick CT scanning and corresponding reconstructed images in all 20 experimental rabbits (Figure&#160;<xref rid="os70149-fig-0004" ref-type="fig">4B,C</xref>). The JIVCC development rate after MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP infusion was significantly greater than that before injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs (tibial JIVCC: <italic toggle="yes">&#967;</italic>
<sup>2</sup>&#8201;=&#8201;40, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001; femoral JIVCC: <italic toggle="yes">&#967;</italic>
<sup>2</sup>&#8201;=&#8201;40, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). Moreover, no enhanced JIVCC imaging of the contralateral extremity was presented, which was significantly different from that of the knee joint placed with the neodymium magnet (tibial JIVCC: <italic toggle="yes">&#967;</italic>
<sup>2</sup>&#8201;=&#8201;40, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001; femoral JIVCC: <italic toggle="yes">&#967;</italic>
<sup>2</sup>&#8201;=&#8201;40, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001).</p><fig position="float" fig-type="FIGURE" id="os70149-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Radiographic and histological findings of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP&#8208;injected rabbits. (A) Experimental rabbits underwent CT scanning, and the neodymium magnet is shown as a high&#8208;density rectangle. (B) Discernible imaging of intraosseous microvessels in the proximal tibial JIVCC (arrowhead) shown on a 1&#8208;mm&#8208;thick reconstructed CT image after intravenous injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs. (C) Discernible imaging of intraosseous microvessels in the distal femoral JIVCC (arrowhead) shown on a 1&#8208;mm&#8208;thick reconstructed CT image after intravenous injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs. (D) MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were found as irregular brown substances (arrowhead) via HE staining in the rabbit JIVCC. (E) MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were found as irregular blue substances (arrowhead) via potassium ferrocyanide staining in the rabbit JIVCC.</p></caption><graphic position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="OS-17-2744-g006.jpg"/></fig></sec><sec id="os70149-sec-0016"><label>3.3</label><title>Histological Characteristics of <styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NPs</styled-content> in <styled-content style="fixed-case" toggle="no">JIVCC</styled-content>
</title><p>The histological characteristics of the 10 rabbits that were sacrificed were revealed. Under HE staining, irregular brown particles were found in the intraosseous blood vessels, which were aggregated with MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs (Figure&#160;<xref rid="os70149-fig-0004" ref-type="fig">4D</xref>). These magnetic composite particles were also identified as irregular blue substances via potassium ferrocyanide staining (Figure&#160;<xref rid="os70149-fig-0004" ref-type="fig">4E</xref>). The histological characteristics of the cells adjacent to the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were normal, and no cellular injury or necrosis was detected (Figure&#160;<xref rid="os70149-fig-0004" ref-type="fig">4D,E</xref>). The detection rate of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs in the JIVCC of the knee joint on the side with a magnet was significantly greater than that on the side without a magnet (<italic toggle="yes">&#967;</italic>
<sup>2</sup>&#8201;=&#8201;7.5, <italic toggle="yes">p</italic>&#8201;=&#8201;0.020).</p></sec><sec id="os70149-sec-0017"><label>3.4</label><title>Safety Verification of <styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NPs</styled-content> In&#160;Vivo</title><p>The urine volume of the 10 surviving rabbits was 519.5&#8201;&#177;&#8201;61.3&#8201;mL 48&#8201;h after anesthesia and recovery, and there was no statistically significant difference from the urine volume of 503.5&#8201;&#177;&#8201;57.8&#8201;mL 48&#8201;h before the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP injection experiment (<italic toggle="yes">t</italic>&#8201;=&#8201;&#8722;1.329, <italic toggle="yes">p</italic>&#8201;=&#8201;0.216) (Table&#160;<xref rid="os70149-tbl-0001" ref-type="table">1</xref>). The urine presented a light yellow color, in which the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were excreted as dark brown flocculent precipitates.</p><table-wrap position="float" id="os70149-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Urine volume and serum iron level in rabbits before and after MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs injection.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Before the injection</th><th align="center" valign="bottom" rowspan="1" colspan="1">4&#8201;h after the injection</th><th align="center" valign="bottom" rowspan="1" colspan="1">72&#8201;h after the injection</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Urine volume in 48&#8201;h (mL)</td><td align="center" valign="top" rowspan="1" colspan="1">503.5&#8201;&#177;&#8201;54.9</td><td align="center" valign="top" rowspan="1" colspan="1">519.5&#8201;&#177;&#8201;58.1</td><td align="center" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic>&#8201;=&#8201;&#8722;1.329, <italic toggle="yes">p</italic>&#8201;=&#8201;0.216</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum iron level (&#956;mol/L)</td><td align="center" valign="top" rowspan="1" colspan="1">23.9&#8201;&#177;&#8201;2.132</td><td align="center" valign="top" rowspan="1" colspan="1">26.2&#8201;&#177;&#8201;2.300</td><td align="center" valign="top" rowspan="1" colspan="1">24.9&#8201;&#177;&#8201;2.331</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">F</italic>&#8201;=&#8201;2.614, <italic toggle="yes">p</italic>&#8201;=&#8201;0.092</td></tr></tbody></table><table-wrap-foot id="os70149-ntgp-0002"><fn id="os70149-note-0003"><p>Abbreviation: MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs: meglumine diatrizoate and Fe<sub>3</sub>O<sub>4</sub> nanoparticles.</p></fn></table-wrap-foot></table-wrap><p>We collected urine and feces from 10 rabbits after MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP injection, extracted, purified, and dissolved them, prepared 100&#8201;mL of phosphate&#8208;buffered saline solution, and converted 3&#8201;mL of the iron content into 0.28&#8201;&#177;&#8201;0.04&#8201;mg of Fe<sub>3</sub>O<sub>4</sub> through biochemical analyzer measurements. The iron levels in the blood before the experiment, 4&#8201;h after the experiment, and 72&#8201;h after the experiment were 23.9&#8201;&#177;&#8201;2.13&#8201;&#956;mol/L, 26.2&#8201;&#177;&#8201;2.30&#8201;&#956;mol/L, and 24.9&#8201;&#177;&#8201;2.33&#8201;&#956;mol/L, respectively, with no statistical difference (<italic toggle="yes">F</italic>&#8201;=&#8201;2.614, <italic toggle="yes">p</italic>&#8201;=&#8201;0.092) (Table&#160;<xref rid="os70149-tbl-0001" ref-type="table">1</xref>). Based on the above findings, MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs can be excreted from urine and feces to guarantee physiological safety in&#160;vivo. In addition, no siderosis was observed in the livers or spleens of any of the experimental animals.</p></sec><sec id="os70149-sec-0018"><label>3.5</label><title>Clinical Perfusion of <styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NPs</styled-content>
</title><p>Following placement of the neodymium magnet (Figure&#160;<xref rid="os70149-fig-0005" ref-type="fig">5A</xref>), a volunteer received MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP intravenous administration as a contrast agent, and 1&#8208;mm&#8208;thick CT scanning of the knee joint was performed. The intraosseous vasculatures in the JIVCC were clearly visualized in both the coronal and sagittal reconstructed images, indicating that this method can reliably develop for the JIVCC (Figure&#160;<xref rid="os70149-fig-0005" ref-type="fig">5B&#8211;E</xref>). We observed radiographic materials from other male adults as a control. As a result, imaging of both proximal tibial and distal femoral JIVCCs can demonstrate only their vascular foramen on the articular facet and partial osseous canal but no distinct intraosseous microvessels on routine 1&#8208;mm&#8208;thick reconstructed coronal and sagittal CT images without the utilization of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs (Figure&#160;<xref rid="os70149-fig-0005" ref-type="fig">5F&#8211;I</xref>). There was also no enhanced JIVCC imaging in the contralateral lower extremity without magnets in the volunteer, and the results were in accordance with those of the animal experiments.</p><fig position="float" fig-type="FIGURE" id="os70149-fig-0005" orientation="portrait"><label>FIGURE 5</label><caption><p>Characteristics of meglumine diatrizoate nanoparticles, amino&#8208;Fe<sub>3</sub>O<sub>4</sub> nanoparticles, and MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs under electron microscopy. (A) Preimaging immediate anteroposterior radiograph of the volunteer; the neodymium magnet is shown as a high&#8208;density rectangle. (B) Discernible imaging of intraosseous microvessels in the distal femoral JIVCC (arrowhead) shown on a 1&#8201;mm&#8208;thick reconstructed sagittal CT image after intravenous injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs in a volunteer. (C) Discernible imaging of intraosseous microvessels in the distal femoral JIVCC (arrowhead) shown on a 1&#8208;mm&#8208;thick reconstructed coronal CT image after intravenous injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs in a volunteer. (D) Discernible imaging of intraosseous microvessels in the proximal tibial JIVCC (arrowhead) shown on a 1&#8208;mm&#8208;thick reconstructed sagittal CT image after intravenous injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs in a volunteer. (E) Discernible imaging of intraosseous microvessels in the proximal tibial JIVCC (arrowhead) shown on a 1&#8208;mm&#8208;thick reconstructed coronal CT image after intravenous injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs in a volunteer. (F) Imaging of distal femoral JIVCC showing its vascular foremen on the articular facet (arrowhead) and osseous canal (arrow) but no distinct intraosseous microvessels on a routine 1&#8208;mm&#8208;thick reconstructed sagittal CT image of a healthy femur from an adult male. (G) Imaging of distal femoral JIVCC showing its vascular foremen on the articular facet (arrowhead) and osseous canal (arrow) but no distinct intraosseous microvessels on a routine 1&#8208;mm&#8208;thick reconstructed coronal CT image of a healthy femur from an adult male. (H) Imaging of proximal tibial JIVCC showing its vascular foremen on the articular facet (arrowhead) and osseous canal (arrow) but no distinct intraosseous microvessels on a routine 1&#8208;mm&#8208;thick reconstructed sagittal CT image of a healthy tibia from an adult male. (I) Imaging of proximal tibial JIVCC showing its vascular foremen on the articular facet (arrowhead) and osseous canal (arrow) but no distinct intraosseous microvessels on a routine 1&#8208;mm&#8208;thick reconstructed coronal CT image of a healthy tibia from an adult male.</p></caption><graphic position="anchor" id="jats-graphic-11" orientation="portrait" xlink:href="OS-17-2744-g007.jpg"/></fig><p>The iron levels in the blood before the experiment, 4&#8201;h after the experiment, and 2&#8201;weeks after the experiment were 17.7&#8201;&#956;mol/L, 19.8&#8201;&#956;mol/L, and 18.2&#8201;&#956;mol/L, respectively, all within the normal safe range, and no adverse events were observed following injection, which demonstrated the safe application of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs in humans (Figure&#160;<xref rid="os70149-fig-0006" ref-type="fig">6</xref>).</p><fig position="float" fig-type="FIGURE" id="os70149-fig-0006" orientation="portrait"><label>FIGURE 6</label><caption><p>Serum iron levels in the volunteer before MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP injection, 4&#8201;h after injection, and 2&#8201;weeks after injection, showing the safe range. The red lines above and below represent the maximum and minimum limits of the safe concentration of serum iron, respectively.</p></caption><graphic position="anchor" id="jats-graphic-13" orientation="portrait" xlink:href="OS-17-2744-g005.jpg"/></fig></sec></sec><sec sec-type="discussion" id="os70149-sec-0019"><label>4</label><title>Discussion</title><sec id="os70149-sec-0020"><label>4.1</label><title>The Main Findings of This Study</title><p>In this investigation, we created a compound nanoparticle composed of MD and SPIONs to facilitate the entrance of contrast agents to intraosseous microvessels, such as JIVCCs, which are arduous steps in previous radiographic studies. We found that these newly synthesized MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs possess adaptable chemical, radiographical, and histological features to achieve the nanoimaging of JIVCC, and their rationality and reliability were validated in&#160;vivo. Moreover, studies of not only animal models but also human blood vessels were carried out to verify that this novel imaging methodology can guarantee both feasibility and safety for further clinical application. To the best of our knowledge, a systematic investigation describing nanoimaging technologies for the juxta&#8208;articular intraosseous vascular system has not been reported in the previous English literature, and MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs were proven to be efficacious, acceptable, and safe for entering such a vascular system through intravenous administration in this investigation.</p></sec><sec id="os70149-sec-0021"><label>4.2</label><title>Key Points for Successful Implementation of <styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NP</styled-content> Imaging of the <styled-content style="fixed-case" toggle="no">JIVCC</styled-content>
</title><p>In this study, we summarize some experiences with the optimized implementation of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP imaging of JIVCC to facilitate its wider application. First, it is important to be familiar with the origin of JIVCCs and the location where they enter the epiphysis and metaphysis to ensure the uneventful completion of such nanoimaging technology [<xref rid="os70149-bib-0005" ref-type="bibr">5</xref>, <xref rid="os70149-bib-0006" ref-type="bibr">6</xref>]. The contrast agent&#8208;enhanced locations of JIVCC on the articular facet of the distal femur and proximal tibia are in accordance with the previously described areas, thus guaranteeing the rationality and dependability of applying MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs for the visualization of JIVCC on the basis of anatomical evidence [<xref rid="os70149-bib-0005" ref-type="bibr">5</xref>]. Second, we found that the 100&#8201;&#177;&#8201;10&#8201;nm SPION consisted of Fe<sub>3</sub>O<sub>4</sub> core particles and amino shells combined with 20&#8201;&#177;&#8201;2&#8201;nm diatrizoated meglumine particles to form composite nanoparticles for JIVCC imaging, resulting in a stable interparticle combination with maps of the equalized distribution of each element [<xref rid="os70149-bib-0024" ref-type="bibr">24</xref>, <xref rid="os70149-bib-0025" ref-type="bibr">25</xref>, <xref rid="os70149-bib-0026" ref-type="bibr">26</xref>]. Finally, when performing JIVCC imaging, we recommend that the magnet should be placed parallel to the targeted JIVCC to ensure the stability and continuity of vascular imaging to the greatest extent. If the magnet is placed vertically, the imaging will be unstable, and the images will be disturbed due to the accelerated flow of magnetic microspheres, dot aggregation, and other potential reasons [<xref rid="os70149-bib-0027" ref-type="bibr">27</xref>, <xref rid="os70149-bib-0028" ref-type="bibr">28</xref>].</p></sec><sec id="os70149-sec-0022"><label>4.3</label><title>Rationality and Safety of <styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NP</styled-content> Imaging for <styled-content style="fixed-case" toggle="no">JIVCC</styled-content>
</title><p>Currently, ferumoxytol is the only SPION approved as a clinical contrast agent carrier and is utilized for contrast enhancement in radiographic detection and imaging [<xref rid="os70149-bib-0029" ref-type="bibr">29</xref>, <xref rid="os70149-bib-0030" ref-type="bibr">30</xref>, <xref rid="os70149-bib-0031" ref-type="bibr">31</xref>, <xref rid="os70149-bib-0032" ref-type="bibr">32</xref>, <xref rid="os70149-bib-0033" ref-type="bibr">33</xref>, <xref rid="os70149-bib-0034" ref-type="bibr">34</xref>]. The rationality of this investigation is also supported by the anatomic characteristics of the JIVCC. On the basis of our previous findings, JIVCCs are firmly confined to the osseous canal with constant internal and external diameters regardless of whether these microvessels are filled, and there is basically no change in the phase of diastole or systole [<xref rid="os70149-bib-0005" ref-type="bibr">5</xref>]. Therefore, the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP contrast agent injected into the circulatory system can enter the JIVCC under natural pressure, providing a dynamic theoretical basis for the reasonable application of such nanoparticles [<xref rid="os70149-bib-0005" ref-type="bibr">5</xref>, <xref rid="os70149-bib-0035" ref-type="bibr">35</xref>]. In recent studies in which Fe<sub>3</sub>O<sub>4</sub>&#8208;based composite NPs were applied for biomedical imaging, histological observations were usually conducted between 1 and 48&#8201;h after injection in animal models to determine the adequate biodistribution of the composite nanoparticles [<xref rid="os70149-bib-0019" ref-type="bibr">19</xref>, <xref rid="os70149-bib-0036" ref-type="bibr">36</xref>]. On the basis of these previous reliable experiences, we recorded the histological and cellular features of the sacrificed experimental animals 48&#8201;h after the injection to ensure a sufficient period of time for scientific evaluation. This study also demonstrated the safety of JIVCC imaging via MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs, as described below. First, we focused on the histological characteristics of HE&#8208;stained JIVCC cells adjacent to the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs and found no cytopathological changes or cell death. Second, previous studies have shown that ferumoxytol nanoparticles are distributed in various tissues and are mainly deposited in the liver and spleen, followed by the brain, heart, and lung, and that the bone is not the organ where SPION accumulates [<xref rid="os70149-bib-0037" ref-type="bibr">37</xref>, <xref rid="os70149-bib-0038" ref-type="bibr">38</xref>]. Finally, the concentration of free iron both 4&#8201;h and 2&#8201;weeks after injection was within the safe range, and no related adverse reactions to injection occurred in this study [<xref rid="os70149-bib-0039" ref-type="bibr">39</xref>]. Compared with previous Fe<sub>3</sub>O<sub>4</sub> NP studies, we also found that the dynamic change trend of the ion concentration in our experimental animals was very similar to that of safe in&#160;vivo biodistribution behaviors and barely hepatic/splenic metallic accumulation [<xref rid="os70149-bib-0036" ref-type="bibr">36</xref>]. Notably, ferumoxytol is regarded as the only clinical SPION&#8208;derived product currently approved by the Food and Drug Administration [<xref rid="os70149-bib-0031" ref-type="bibr">31</xref>]. Moreover, similar drug&#8208;coated Fe<sub>3</sub>O<sub>4</sub> nanoparticles have also been verified to have no immunogenicity that leads to unexpected immune responses or autoimmune diseases [<xref rid="os70149-bib-0040" ref-type="bibr">40</xref>].</p></sec><sec id="os70149-sec-0023"><label>4.4</label><title>Clinical Significance and Application Prospects of <styled-content style="fixed-case" toggle="no">MD</styled-content>&#8208;<styled-content style="fixed-case" toggle="no">Fe<sub>3</sub>O<sub>4</sub> NP</styled-content> Imaging of <styled-content style="fixed-case" toggle="no">JIVCC</styled-content>
</title><p>This study provides a sufficient preliminary basis for extensive clinical radiographic applications of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP imaging of JIVCC via CT and MRI under the induction of an appropriate magnetic field [<xref rid="os70149-bib-0036" ref-type="bibr">36</xref>, <xref rid="os70149-bib-0041" ref-type="bibr">41</xref>]. The JIVCC imaging methodology for MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs involves intravenous infusion, which is the most common clinical injection modality [<xref rid="os70149-bib-0031" ref-type="bibr">31</xref>]. Moreover, the intra&#8208;articular injection of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs can facilitate the intraoperative localization of JIVCC in minimally invasive treatment, arthroscopic surgery, and open surgery [<xref rid="os70149-bib-0042" ref-type="bibr">42</xref>, <xref rid="os70149-bib-0043" ref-type="bibr">43</xref>]. SPIONs can also carry chemotherapy drugs such as doxorubicin to achieve precise antitumor treatment, which has been implemented in the treatment of malignant neoplasms, including breast, ovarian, and cervical cancers [<xref rid="os70149-bib-0031" ref-type="bibr">31</xref>, <xref rid="os70149-bib-0044" ref-type="bibr">44</xref>]. The successful applications of SPIONs in previous oncologic studies indicate that the novel nanoimaging technology described in this study also possesses potential extensive prospects for clinical application in corresponding scopes, such as intraosseous precise chemotherapy of osseous malignant neoplasms such as osteosarcoma. In this study, the appropriate implementation of a magnetic field also played a vital role in the successful application of this new methodology. We plan to gradually establish the magnetic field as a standardized clinical workflow following the three stages described below. In the first stage, the external neodymium magnet may have to be physically placed around the joint with a parallel orientation to the targeted JIVCC, and this neodymium magnet is preferentially recommended to be placed in the lateral position in the anteroposterior direction. The external neodymium magnets can be fixed with the help of an assembled or 3D&#8208;printed immobilization brace. In the second stage, we can simplify the setup of the magnetic field in the related surgeries by utilizing an internal neodymium magnet that can be attached to a hemoclip. The magnetic anchored setup can be placed into the intra&#8208;articular&#8208;oriented vessels for the targeted JIVCC (e.g., middle genicular veins for femoral and tibial JIVCCs), and the detailed procedures are similar to those of magnetic anchor&#8208;guided endoscopic submucosal dissection&#160;[<xref rid="os70149-bib-0045" ref-type="bibr">45</xref>]. In the last stage, we expect to implement a mature and stable electromagnetic field such as transcranial magnetic stimulation to finally realize a convenient routine clinical application of MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NP nanoimaging methodology to visualize the intraosseous microvessels.</p><p>Currently, it is still arduous to implement large&#8208;scale clinical investigations involving multiple patients for the studies focused on the intraosseous and transosseous microvessels and canals; therefore, initial observations of femoral, tibial, and fibular TCVs were first conducted on each single participant [<xref rid="os70149-bib-0003" ref-type="bibr">3</xref>]. Moreover, many medical nanoimaging studies are currently only able to be conducted on experimental animals or cell lines, but without the verification of clinical participants due to diverse technological or security considerations [<xref rid="os70149-bib-0019" ref-type="bibr">19</xref>, <xref rid="os70149-bib-0025" ref-type="bibr">25</xref>, <xref rid="os70149-bib-0046" ref-type="bibr">46</xref>]. Because of these inevitable limits, only one human volunteer was included in this clinical pilot study, and we plan to enroll more clinical cases in our future series studies to increase the broader applicability of this nanoimaging methodology. Furthermore, retrospective CT images that use MD as a contrast agent will also be included in follow&#8208;up investigations to conduct a gradient comparison between MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs, single MD injections, and other routine contrast agents for the clinical imaging effect of JIVCC.</p></sec></sec><sec id="os70149-sec-0024"><label>5</label><title>Strengths and Limitations</title><p>An important strength of our study design is the cooperative application of SPIONs and MD, which are both regarded as clinically reliable materials. They guarantee the safety and feasibility to realize the effective visualization of intraosseous microvessels. Besides, this nanoimaging technology was successfully implemented in the enrolled volunteer, indicating that this investigation design is very suitable for real clinical radiographic practices. The main limitations of our study are as follows. First, to ensure safety, the different temperatures and pH values were not adjusted in&#160;vivo to test the potentially variable properties of the MD&#8208;Fe<sub>3</sub>O<sub>4</sub> NPs. Moreover, it must be acknowledged that the number of volunteers enrolled in this study was limited, and the universality of our results should be further validated if large&#8208;scale investigations are conducted in the future.</p></sec><sec sec-type="conclusions" id="os70149-sec-0025"><label>6</label><title>Conclusion</title><p>In this investigation, we created a compound nanoparticle composed of MD and amino&#8208;Fe<sub>3</sub>O<sub>4</sub> to achieve contrast imaging of juxta&#8208;articular intraosseous microvessels, which has been challenging in previous radiographic and orthopedic investigations. On the basis of not only animal models but also human blood vessels, this novel nanoimaging methodology is verified to guarantee both feasibility and safety and therefore can be further implemented for related clinical applications.</p></sec><sec id="os70149-sec-0026"><title>Author Contributions</title><p>Kun Cheng, Guanghui Wang, Jing Li, Xia Su, and Xianhao Shao designed the study. Jianmin Li and Zhenzhong Li supervised the investigation. Mengmeng Dou and Jinfeng Yang conducted the majority of this study and analyzed data. Jiaoran Li and Xianhao Shao prepared the manuscript. Mengmeng Dou, Jinfeng Yang, Jiaoran Li, Kun Cheng, and Xianhao Shao helped with correlative imaging steps. Mengmeng Dou, Jinfeng Yang, and Xianhao Shao helped with radiographic observations and measurements. Kun Cheng and Jiaoran Li helped with histological examinations. Jianmin Li, Zhenzhong Li, Guanghui Wang, Jing Li, and Kun Cheng revised the manuscript. All authors contributed to the article and approved the submitted version.</p></sec><sec id="os70149-sec-0028"><title>Ethics Statement</title><p>The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Medical Ethics Committee of Medical School, Shandong University (No. LL&#8208;2020&#8208;1&#8208;052).</p></sec><sec sec-type="conclusions" id="os70149-sec-0029"><title>Consent</title><p>The authors have nothing to report.</p></sec><sec sec-type="COI-statement" id="os70149-sec-0030"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec></body><back><ack id="os70149-sec-0027"><title>Acknowledgments</title><p>The authors thank the Department of Pathology, Qilu Hospital (Qingdao) for histological determination. The authors thank the Department of Radiography, Qilu Hospital (Qingdao) and the Department of Radiography, Tianjin First Central Hospital, for radiographic verification. They extend their gratitude to the experimental support from Shandong Provincial Hospital. They also thank Dr. Shimo Yu for his professional guidance in the field of chemical analysis.</p></ack><sec sec-type="data-availability" id="os70149-sec-0032"><title>Data Availability Statement</title><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></sec><ref-list content-type="cited-references" id="os70149-bibl-0001"><title>References</title><ref id="os70149-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="os70149-cit-0001"><string-name name-style="western"><given-names>A. P.</given-names><surname>Kusumbe</surname></string-name>, <string-name name-style="western"><given-names>S. K.</given-names><surname>Ramasamy</surname></string-name>, and <string-name name-style="western"><given-names>R. H.</given-names><surname>Adams</surname></string-name>, &#8220;<article-title>Coupling of Angiogenesis and Osteogenesis by a Specific Vessel Subtype in Bone</article-title>,&#8221; <source>Nature</source><volume>507</volume>, no. <issue>7492</issue> (<year>2014</year>): <fpage>323</fpage>&#8211;<lpage>328</lpage>.<pub-id pub-id-type="pmid">24646994</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature13145</pub-id><pub-id pub-id-type="pmcid">PMC4943525</pub-id></mixed-citation></ref><ref id="os70149-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="os70149-cit-0002"><string-name name-style="western"><given-names>X.</given-names><surname>Shao</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Dou</surname></string-name>, <string-name name-style="western"><given-names>Q.</given-names><surname>Yang</surname></string-name>, et&#160;al., &#8220;<article-title>Reconstruction of Massive Bone Defects After Femoral Tumor Resection Using Two New&#8208;Designed 3D&#8208;Printed Intercalary Prostheses: A Clinical Analytic Study With the Cooperative Utilization of Multiple Technologies</article-title>,&#8221; <source>BMC Musculoskeletal Disorders</source><volume>24</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>67</fpage>.<pub-id pub-id-type="pmid">36698116</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12891-023-06171-w</pub-id><pub-id pub-id-type="pmcid">PMC9875495</pub-id></mixed-citation></ref><ref id="os70149-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="os70149-cit-0003"><string-name name-style="western"><given-names>A.</given-names><surname>Gr&#252;neboom</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Hawwari</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Weidner</surname></string-name>, et&#160;al., &#8220;<article-title>A Network of Trans&#8208;Cortical Capillaries as Mainstay for Blood Circulation in Long Bones</article-title>,&#8221; <source>Nature Metabolism</source><volume>1</volume>, no. <issue>2</issue> (<year>2019</year>): <fpage>236</fpage>&#8211;<lpage>250</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42255-018-0016-5</pub-id><pub-id pub-id-type="pmcid">PMC6795552</pub-id><pub-id pub-id-type="pmid">31620676</pub-id></mixed-citation></ref><ref id="os70149-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="os70149-cit-0004"><string-name name-style="western"><given-names>A.</given-names><surname>Gr&#252;neboom</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Kling</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Christiansen</surname></string-name>, et&#160;al., &#8220;<article-title>Next&#8208;Generation Imaging of the Skeletal System and Its Blood Supply</article-title>,&#8221; <source>Nature Reviews Rheumatology</source><volume>15</volume>, no. <issue>9</issue> (<year>2019</year>): <fpage>533</fpage>&#8211;<lpage>549</lpage>.<pub-id pub-id-type="pmid">31395974</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41584-019-0274-y</pub-id></mixed-citation></ref><ref id="os70149-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="os70149-cit-0005"><string-name name-style="western"><given-names>X.</given-names><surname>Shao</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Li</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Zhang</surname></string-name>, et&#160;al., &#8220;<article-title>Discovery of Lijianmin&#8208;Chengkun Complexes and Their Oncological Application in Osseous and Intraarticular Lesions Around the Knee</article-title>,&#8221; <source>Frontiers in Surgery</source><volume>8</volume> (<year>2021</year>): <elocation-id>691362</elocation-id>.<pub-id pub-id-type="pmid">34926562</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fsurg.2021.691362</pub-id><pub-id pub-id-type="pmcid">PMC8677826</pub-id></mixed-citation></ref><ref id="os70149-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="os70149-cit-0006"><string-name name-style="western"><given-names>X.</given-names><surname>Shao</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Li</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Zhang</surname></string-name>, et&#160;al., &#8220;<article-title>Discovery and Characterization of Intercondylar Transphyseal Complexes and Their Oncological Significance in Transphyseal Extension of Pediatric Osteosarcoma</article-title>,&#8221; <source>Orthopaedic Surgery</source><volume>14</volume>, no. <issue>2</issue> (<year>2022</year>): <fpage>411</fpage>&#8211;<lpage>421</lpage>.<pub-id pub-id-type="pmid">35199961</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/os.13221</pub-id><pub-id pub-id-type="pmcid">PMC8867409</pub-id></mixed-citation></ref><ref id="os70149-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="os70149-cit-0007"><string-name name-style="western"><given-names>M. H.</given-names><surname>Kim</surname></string-name> and <string-name name-style="western"><given-names>D. W.</given-names><surname>Kim</surname></string-name>, &#8220;<article-title>Incidental Detection of Iliac Artery Occlusion on 3&#8208;Phase Bone Scintigraphy</article-title>,&#8221; <source>Clinical Nuclear Medicine</source><volume>44</volume>, no. <issue>12</issue> (<year>2019</year>): <fpage>966</fpage>&#8211;<lpage>968</lpage>.<pub-id pub-id-type="pmid">31689278</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/RLU.0000000000002815</pub-id></mixed-citation></ref><ref id="os70149-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="os70149-cit-0008"><string-name name-style="western"><given-names>J.</given-names><surname>Huisken</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Swoger</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Del Bene</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Wittbrodt</surname></string-name>, and <string-name name-style="western"><given-names>E. H. K.</given-names><surname>Stelzer</surname></string-name>, &#8220;<article-title>Optical Sectioning Deep Inside Live Embryos by Selective Plane Illumination Microscopy</article-title>,&#8221; <source>Science</source><volume>305</volume>, no. <issue>5686</issue> (<year>2004</year>): <fpage>1007</fpage>&#8211;<lpage>1009</lpage>.<pub-id pub-id-type="pmid">15310904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1100035</pub-id></mixed-citation></ref><ref id="os70149-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="os70149-cit-0009"><string-name name-style="western"><given-names>S.</given-names><surname>Johst</surname></string-name>, <string-name name-style="western"><given-names>K. H.</given-names><surname>Wrede</surname></string-name>, <string-name name-style="western"><given-names>M. E.</given-names><surname>Ladd</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Maderwald</surname></string-name>, &#8220;<article-title>Time&#8208;of&#8208;Flight Magnetic Resonance Angiography at 7T Using Venous Saturation Pulses With Reduced Flip Angles</article-title>,&#8221; <source>Investigative Radiology</source><volume>47</volume>, no. <issue>8</issue> (<year>2012</year>): <fpage>445</fpage>&#8211;<lpage>450</lpage>.<pub-id pub-id-type="pmid">22766907</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/RLI.0b013e31824ef21f</pub-id></mixed-citation></ref><ref id="os70149-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="os70149-cit-0010"><string-name name-style="western"><given-names>A.</given-names><surname>Kolb</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Robinson</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Stelzeneder</surname></string-name>, et&#160;al., &#8220;<article-title>Vessel Architecture in Human Knee Cartilage in Children: An In&#160;Vivo Susceptibility&#8208;Weighted Imaging Study at 7T</article-title>,&#8221; <source>European Radiology</source><volume>28</volume>, no. <issue>8</issue> (<year>2018</year>): <fpage>3384</fpage>&#8211;<lpage>3392</lpage>.<pub-id pub-id-type="pmid">29484458</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00330-017-5290-1</pub-id><pub-id pub-id-type="pmcid">PMC6028839</pub-id></mixed-citation></ref><ref id="os70149-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="os70149-cit-0011"><string-name name-style="western"><given-names>Z.</given-names><surname>Liao</surname></string-name>, <string-name name-style="western"><given-names>Q.</given-names><surname>Bai</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Ming</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Ma</surname></string-name>, <string-name name-style="western"><given-names>Z.</given-names><surname>Wang</surname></string-name>, and <string-name name-style="western"><given-names>T.</given-names><surname>Gong</surname></string-name>, &#8220;<article-title>Detection of Vascularity of Femoral Head Using Sub&#8208;Millimeter Resolution Steady&#8208;State Magnetic Resonance Angiography&#8212;Initial Experience</article-title>,&#8221; <source>International Orthopaedics</source><volume>44</volume>, no. <issue>6</issue> (<year>2020</year>): <fpage>1115</fpage>&#8211;<lpage>1121</lpage>.<pub-id pub-id-type="pmid">32296907</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00264-020-04564-3</pub-id></mixed-citation></ref><ref id="os70149-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="os70149-cit-0012"><string-name name-style="western"><given-names>K.</given-names><surname>Wang</surname></string-name>, <string-name name-style="western"><given-names>Z.</given-names><surname>Wu</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Gong</surname></string-name>, <string-name name-style="western"><given-names>G.</given-names><surname>Zhao</surname></string-name>, and <string-name name-style="western"><given-names>H.</given-names><surname>Zhang</surname></string-name>, &#8220;<article-title>TGF&#8208;&#946;1 Inhibits Osteoclast Differentiation and Abnormal Angiogenesis in Intervertebral Disc Degeneration: Evidence From RNA Sequencing and Animal Studies</article-title>,&#8221; <source>Orthopaedic Surgery</source><volume>16</volume>, no. <issue>1</issue> (<year>2024</year>): <fpage>167</fpage>&#8211;<lpage>182</lpage>.<pub-id pub-id-type="pmid">38014468</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/os.13912</pub-id><pub-id pub-id-type="pmcid">PMC10782258</pub-id></mixed-citation></ref><ref id="os70149-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="os70149-cit-0013"><string-name name-style="western"><given-names>G.</given-names><surname>Zheng</surname></string-name>, <string-name name-style="western"><given-names>X.</given-names><surname>Qiu</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Wang</surname></string-name>, and <string-name name-style="western"><given-names>D.</given-names><surname>Zhao</surname></string-name>, &#8220;<article-title>Relationship Between Blood Flow and Collapse of Nontraumatic Osteonecrosis of the Femoral Head</article-title>,&#8221; <source>Journal of Bone and Joint Surgery. American Volume</source><volume>104</volume>, no. <issue>S2</issue> (<year>2022</year>): <fpage>13</fpage>&#8211;<lpage>18</lpage>.<pub-id pub-id-type="pmid">35389902</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.20.00490</pub-id></mixed-citation></ref><ref id="os70149-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="os70149-cit-0014"><string-name name-style="western"><given-names>W.</given-names><surname>Chen</surname></string-name>, <string-name name-style="western"><given-names>W.</given-names><surname>Du</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Wu</surname></string-name>, et&#160;al., &#8220;<article-title>Outcomes of Free Vascularized Iliac Bone Flap for Severe Traumatic Osteonecrosis of Femoral Head in Young Adults</article-title>,&#8221; <source>European Journal of Trauma and Emergency Surgery</source><volume>49</volume>, no. <issue>3</issue> (<year>2023</year>): <fpage>1417</fpage>&#8211;<lpage>1424</lpage>.<pub-id pub-id-type="pmid">36469082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00068-022-02183-8</pub-id></mixed-citation></ref><ref id="os70149-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="os70149-cit-0015"><string-name name-style="western"><given-names>L.</given-names><surname>Wang</surname></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Luo</surname></string-name>, <string-name name-style="western"><given-names>X.</given-names><surname>Qiu</surname></string-name>, et&#160;al., &#8220;<article-title>Analysis of Animal Models of Traumatic Osteonecrosis of the Femoral Head Based on Blood Supply: A Literature Review</article-title>,&#8221; <source>Orthopaedic Surgery</source><volume>17</volume>, no. <issue>3</issue> (<year>2025</year>): <fpage>703</fpage>&#8211;<lpage>713</lpage>.<pub-id pub-id-type="pmid">39837780</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/os.14352</pub-id><pub-id pub-id-type="pmcid">PMC11872375</pub-id></mixed-citation></ref><ref id="os70149-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="os70149-cit-0016"><string-name name-style="western"><given-names>J. H.</given-names><surname>Ji</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Parikh</surname></string-name>, <string-name name-style="western"><given-names>B. J.</given-names><surname>Hwang</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Jeong</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Oh</surname></string-name>, &#8220;<article-title>Extra&#8208;Articular Abscess Expansion as a Specific Complication of Septic Arthritis of the Shoulder Joint: Report of Three Cases With Extension of the Infection Through the Biceps Groove Producing a Large Abscess</article-title>,&#8221; <source>Orthopaedic Surgery</source><volume>16</volume>, no. <issue>10</issue> (<year>2024</year>): <fpage>2574</fpage>&#8211;<lpage>2581</lpage>.<pub-id pub-id-type="pmid">39223827</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/os.14210</pub-id><pub-id pub-id-type="pmcid">PMC11456744</pub-id></mixed-citation></ref><ref id="os70149-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="os70149-cit-0017"><string-name name-style="western"><given-names>S.</given-names><surname>Sabale</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Kandesar</surname></string-name>, <string-name name-style="western"><given-names>V.</given-names><surname>Jadhav</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Komorek</surname></string-name>, <string-name name-style="western"><given-names>R. K.</given-names><surname>Motkuri</surname></string-name>, and <string-name name-style="western"><given-names>X. Y.</given-names><surname>Yu</surname></string-name>, &#8220;<article-title>Recent Development in Synthesis, Properties, and Biomedical Applications of Core/Shell Superparamagnetic Iron Oxide Nanoparticles With Gold</article-title>,&#8221; <source>Biomaterials Science</source><volume>5</volume>, no. <issue>11</issue> (<year>2017</year>): <fpage>2212</fpage>&#8211;<lpage>2225</lpage>.<pub-id pub-id-type="pmid">28901350</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/c7bm00723j</pub-id></mixed-citation></ref><ref id="os70149-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="os70149-cit-0018"><string-name name-style="western"><given-names>V.</given-names><surname>Tsampasian</surname></string-name>, <string-name name-style="western"><given-names>A. J.</given-names><surname>Swift</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Assadi</surname></string-name>, et&#160;al., &#8220;<article-title>Myocardial Inflammation and Energetics by Cardiac MRI: A Review of Emerging Techniques</article-title>,&#8221; <source>BMC Medical Imaging</source><volume>21</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>164</fpage>.<pub-id pub-id-type="pmid">34749671</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12880-021-00695-0</pub-id><pub-id pub-id-type="pmcid">PMC8573867</pub-id></mixed-citation></ref><ref id="os70149-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="os70149-cit-0019"><string-name name-style="western"><given-names>Z.</given-names><surname>Wang</surname></string-name>, <string-name name-style="western"><given-names>G.</given-names><surname>Wang</surname></string-name>, <string-name name-style="western"><given-names>T.</given-names><surname>Kang</surname></string-name>, et&#160;al., &#8220;<article-title>BiVO<sub>4</sub>/Fe<sub>3</sub>O<sub>4</sub>@polydopamine Superparticles for Tumor Multimodal Imaging and Synergistic Therapy</article-title>,&#8221; <source>Journal of Nanobiotechnology</source><volume>19</volume>, no. <issue>1</issue> (<year>2021</year>): <elocation-id>90</elocation-id>.<pub-id pub-id-type="pmid">33781296</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-021-00802-x</pub-id><pub-id pub-id-type="pmcid">PMC8008624</pub-id></mixed-citation></ref><ref id="os70149-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="os70149-cit-0020"><string-name name-style="western"><given-names>I.</given-names><surname>Sanaullah</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Imran</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Riaz</surname></string-name>, et&#160;al., &#8220;<article-title>Microwave Assisted Synthesis of Fe<sub>3</sub>O<sub>4</sub> Stabilized ZrO<sub>2</sub> Nanoparticles &#8211; Free Radical Scavenging, Radiolabeling and Biodistribution in Rabbits</article-title>,&#8221; <source>Life Sciences</source><volume>271</volume> (<year>2021</year>): <elocation-id>119070</elocation-id>.<pub-id pub-id-type="pmid">33465388</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2021.119070</pub-id></mixed-citation></ref><ref id="os70149-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="os70149-cit-0021"><string-name name-style="western"><given-names>M.</given-names><surname>Makita</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Manabe</surname></string-name>, <string-name name-style="western"><given-names>T.</given-names><surname>Kurita</surname></string-name>, et&#160;al., &#8220;<article-title>Moving a Neodymium Magnet Promotes the Migration of a Magnetic Tracer and Increases the Monitoring Counts on the Skin Surface of Sentinel Lymph Nodes in Breast Cancer</article-title>,&#8221; <source>BMC Medical Imaging</source><volume>20</volume>, no. <issue>1</issue> (<year>2020</year>): <fpage>58</fpage>.<pub-id pub-id-type="pmid">32460834</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12880-020-00459-2</pub-id><pub-id pub-id-type="pmcid">PMC7254765</pub-id></mixed-citation></ref><ref id="os70149-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="os70149-cit-0022"><string-name name-style="western"><given-names>A. M. M.</given-names><surname>Dias</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Courteau</surname></string-name>, <string-name name-style="western"><given-names>P. S.</given-names><surname>Bellaye</surname></string-name>, et&#160;al., &#8220;<article-title>Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers Through Macrophages and Magnetic Hyperthermia</article-title>,&#8221; <source>Pharmaceutics</source><volume>14</volume>, no. <issue>11</issue> (<year>2022</year>): <elocation-id>2388</elocation-id>.<pub-id pub-id-type="pmid">36365207</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/pharmaceutics14112388</pub-id><pub-id pub-id-type="pmcid">PMC9694944</pub-id></mixed-citation></ref><ref id="os70149-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="os70149-cit-0023"><string-name name-style="western"><given-names>C.</given-names><surname>Camaschella</surname></string-name>, &#8220;<article-title>Iron Deficiency: New Insights Into Diagnosis and Treatment</article-title>,&#8221; <source>Hematology. American Society of Hematology. Education Program</source><volume>2015</volume> (<year>2015</year>): <fpage>8</fpage>&#8211;<lpage>13</lpage>.<pub-id pub-id-type="pmid">26637694</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/asheducation-2015.1.8</pub-id></mixed-citation></ref><ref id="os70149-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="os70149-cit-0024"><string-name name-style="western"><given-names>A.</given-names><surname>Petri&#8208;Fink</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Chastellain</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Juillerat&#8208;Jeanneret</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Ferrari</surname></string-name>, and <string-name name-style="western"><given-names>H.</given-names><surname>Hofmann</surname></string-name>, &#8220;<article-title>Development of Functionalized Superparamagnetic Iron Oxide Nanoparticles for Interaction With Human Cancer Cells</article-title>,&#8221; <source>Biomaterials</source><volume>26</volume>, no. <issue>15</issue> (<year>2005</year>): <fpage>2685</fpage>&#8211;<lpage>2694</lpage>.<pub-id pub-id-type="pmid">15585272</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biomaterials.2004.07.023</pub-id></mixed-citation></ref><ref id="os70149-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="os70149-cit-0025"><string-name name-style="western"><given-names>K.</given-names><surname>Luo</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Zhao</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Jia</surname></string-name>, et&#160;al., &#8220;<article-title>Integration of Fe<sub>3</sub>O<sub>4</sub> With Bi<sub>2</sub>S<sub>3</sub> for Multi&#8208;Modality Tumor Theranostics</article-title>,&#8221; <source>ACS Applied Materials &amp; Interfaces</source><volume>12</volume>, no. <issue>20</issue> (<year>2020</year>): <fpage>22650</fpage>&#8211;<lpage>22660</lpage>.<pub-id pub-id-type="pmid">32330380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsami.0c05088</pub-id></mixed-citation></ref><ref id="os70149-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="os70149-cit-0026"><string-name name-style="western"><given-names>I.</given-names><surname>Antal</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Koneracka</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Kubovcikova</surname></string-name>, et&#160;al., &#8220;<article-title>
<sc>d</sc>,<sc>l</sc>&#8208;Lysine Functionalized Fe<sub>3</sub>O<sub>4</sub> Nanoparticles for Detection of Cancer Cells</article-title>,&#8221; <source>Colloids and Surfaces B: Biointerfaces</source><volume>163</volume> (<year>2018</year>): <fpage>236</fpage>&#8211;<lpage>245</lpage>.<pub-id pub-id-type="pmid">29306846</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.colsurfb.2017.12.022</pub-id></mixed-citation></ref><ref id="os70149-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="os70149-cit-0027"><string-name name-style="western"><given-names>S.</given-names><surname>Buch</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Subramanian</surname></string-name>, <string-name name-style="western"><given-names>P. K.</given-names><surname>Jella</surname></string-name>, et&#160;al., &#8220;<article-title>Revealing Vascular Abnormalities and Measuring Small Vessel Density in Multiple Sclerosis Lesions Using USPIO</article-title>,&#8221; <source>Neuroimage. Clinical</source><volume>29</volume> (<year>2021</year>): <elocation-id>102525</elocation-id>.<pub-id pub-id-type="pmid">33338965</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nicl.2020.102525</pub-id><pub-id pub-id-type="pmcid">PMC7750444</pub-id></mixed-citation></ref><ref id="os70149-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="os70149-cit-0028"><string-name name-style="western"><given-names>J. E.</given-names><surname>Caterini</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Rendall</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Cifra</surname></string-name>, et&#160;al., &#8220;<article-title>Non&#8208;Invasive MR Imaging Techniques for Measuring Femoral Arterial Flow in a Pediatric and Adolescent Cohort</article-title>,&#8221; <source>Physiological Reports</source><volume>10</volume>, no. <issue>10</issue> (<year>2022</year>): <elocation-id>e15182</elocation-id>.<pub-id pub-id-type="pmid">35614568</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14814/phy2.15182</pub-id><pub-id pub-id-type="pmcid">PMC9133543</pub-id></mixed-citation></ref><ref id="os70149-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="os70149-cit-0029"><string-name name-style="western"><given-names>X.</given-names><surname>Xue</surname></string-name>, <string-name name-style="western"><given-names>Z.</given-names><surname>Qi</surname></string-name>, <string-name name-style="western"><given-names>Z.</given-names><surname>Wang</surname></string-name>, et&#160;al., &#8220;<article-title>Urushiol&#8208;Dextran SPIONs Magnetic Recyclable Nanoparticles Immobilizing Vancomycin (V@DU@Fe) for Antibacterial Application</article-title>,&#8221; <source>International Journal of Biological Macromolecules</source><volume>304</volume>, no. <issue>Pt 2</issue> (<year>2025</year>): <elocation-id>140847</elocation-id>.<pub-id pub-id-type="pmid">39954904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijbiomac.2025.140847</pub-id></mixed-citation></ref><ref id="os70149-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="os70149-cit-0030"><string-name name-style="western"><given-names>S. M.</given-names><surname>Huang</surname></string-name>, <string-name name-style="western"><given-names>C. Y.</given-names><surname>Wu</surname></string-name>, <string-name name-style="western"><given-names>Y. H.</given-names><surname>Lin</surname></string-name>, et&#160;al., &#8220;<article-title>Differences in Brain Activity Between Normal and Diabetic Rats Under Isofurane Anesthesia: A Resting&#8208;State Functional MRI Study</article-title>,&#8221; <source>BMC Medical Imaging</source><volume>22</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>136</fpage>.<pub-id pub-id-type="pmid">35927630</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12880-022-00867-6</pub-id><pub-id pub-id-type="pmcid">PMC9354416</pub-id></mixed-citation></ref><ref id="os70149-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="os70149-cit-0031"><string-name name-style="western"><given-names>S.</given-names><surname>Talluri</surname></string-name> and <string-name name-style="western"><given-names>R. R.</given-names><surname>Malla</surname></string-name>, &#8220;<article-title>Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Diagnosis and Treatment of Breast, Ovarian and Cervical Cancers</article-title>,&#8221; <source>Current Drug Metabolism</source><volume>20</volume>, no. <issue>12</issue> (<year>2019</year>): <fpage>942</fpage>&#8211;<lpage>945</lpage>.<pub-id pub-id-type="pmid">31622217</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1389200220666191016124958</pub-id></mixed-citation></ref><ref id="os70149-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="os70149-cit-0032"><string-name name-style="western"><given-names>M. D.</given-names><surname>Garrido</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Hamawandi</surname></string-name>, <string-name name-style="western"><given-names>J. F.</given-names><surname>Serrano&#8208;Claumarchirant</surname></string-name>, et&#160;al., &#8220;<article-title>A Rapid Synthesis of Magnetic&#8208;Core Mesoporous Silica&#8208;Shell Nanostructures &#8211; As Potential Theranostic Agents &#8211; By Means of Microwave Irradiation and the Atrane Method</article-title>,&#8221; <source>Nanoscale</source><volume>17</volume>, no. <issue>11</issue> (<year>2025</year>): <fpage>6539</fpage>&#8211;<lpage>6549</lpage>.<pub-id pub-id-type="pmid">39957369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d4nr04572f</pub-id></mixed-citation></ref><ref id="os70149-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="os70149-cit-0033"><string-name name-style="western"><given-names>J.</given-names><surname>Duli&#324;ska&#8208;Litewka</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>&#321;azarczyk</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Ha&#322;ubiec</surname></string-name>, <string-name name-style="western"><given-names>O.</given-names><surname>Szafra&#324;ski</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Karnas</surname></string-name>, and <string-name name-style="western"><given-names>A.</given-names><surname>Karewicz</surname></string-name>, &#8220;<article-title>Superparamagnetic Iron Oxide Nanoparticles&#8212;Current and Prospective Medical Applications</article-title>,&#8221; <source>Materials (Basel)</source><volume>12</volume>, no. <issue>4</issue> (<year>2019</year>): <elocation-id>617</elocation-id>.<pub-id pub-id-type="pmid">30791358</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ma12040617</pub-id><pub-id pub-id-type="pmcid">PMC6416629</pub-id></mixed-citation></ref><ref id="os70149-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="os70149-cit-0034"><string-name name-style="western"><given-names>A. J.</given-names><surname>Franco</surname></string-name> and <string-name name-style="western"><given-names>E.</given-names><surname>Alocilja</surname></string-name>, &#8220;<article-title>Adsorption Studies of <italic toggle="yes">Salmonella</italic> Enteritidis and <italic toggle="yes">Escherichia coli</italic> on Chitosan&#8208;Coated Magnetic Nanoparticles</article-title>,&#8221; <source>Cells</source><volume>14</volume>, no. <issue>3</issue> (<year>2025</year>): <elocation-id>225</elocation-id>.<pub-id pub-id-type="pmid">39937016</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cells14030225</pub-id><pub-id pub-id-type="pmcid">PMC11817960</pub-id></mixed-citation></ref><ref id="os70149-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="os70149-cit-0035"><string-name name-style="western"><given-names>S.</given-names><surname>Zilber</surname></string-name>, <string-name name-style="western"><given-names>N. J.</given-names><surname>Epstein</surname></string-name>, <string-name name-style="western"><given-names>S. W.</given-names><surname>Lee</surname></string-name>, et&#160;al., &#8220;<article-title>Mouse Femoral Intramedullary Injection Model: Technique and microCT Scan Validation</article-title>,&#8221; <source>Journal of Biomedical Materials Research. Part B, Applied Biomaterials</source><volume>84</volume>, no. <issue>1</issue> (<year>2008</year>): <fpage>286</fpage>&#8211;<lpage>290</lpage>.<pub-id pub-id-type="pmid">17563101</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jbm.b.30872</pub-id></mixed-citation></ref><ref id="os70149-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="os70149-cit-0036"><string-name name-style="western"><given-names>J.</given-names><surname>Li</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Zheng</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Cai</surname></string-name>, et&#160;al., &#8220;<article-title>Facile One&#8208;Pot Synthesis of Fe<sub>3</sub>O<sub>4</sub>@Au Composite Nanoparticles for Dual&#8208;Mode MR/CT Imaging Applications</article-title>,&#8221; <source>ACS Applied Materials &amp; Interfaces</source><volume>5</volume>, no. <issue>20</issue> (<year>2013</year>): <fpage>10357</fpage>&#8211;<lpage>10366</lpage>.<pub-id pub-id-type="pmid">24063810</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/am4034526</pub-id></mixed-citation></ref><ref id="os70149-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="os70149-cit-0037"><string-name name-style="western"><given-names>S.</given-names><surname>Laurent</surname></string-name>, <string-name name-style="western"><given-names>A. A.</given-names><surname>Saei</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Behzadi</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Panahifar</surname></string-name>, and <string-name name-style="western"><given-names>M.</given-names><surname>Mahmoudi</surname></string-name>, &#8220;<article-title>Superparamagnetic Iron Oxide Nanoparticles for Delivery of Therapeutic Agents: Opportunities and Challenges</article-title>,&#8221; <source>Expert Opinion on Drug Delivery</source><volume>11</volume>, no. <issue>9</issue> (<year>2014</year>): <fpage>1449</fpage>&#8211;<lpage>1470</lpage>.<pub-id pub-id-type="pmid">24870351</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1517/17425247.2014.924501</pub-id></mixed-citation></ref><ref id="os70149-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="os70149-cit-0038"><string-name name-style="western"><given-names>J.</given-names><surname>Wang</surname></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Chen</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Chen</surname></string-name>, et&#160;al., &#8220;<article-title>Pharmacokinetic Parameters and Tissue Distribution of Magnetic Fe<sub>3</sub>O<sub>4</sub> Nanoparticles in Mice</article-title>,&#8221; <source>International Journal of Nanomedicine</source><volume>5</volume> (<year>2010</year>): <fpage>861</fpage>&#8211;<lpage>866</lpage>.<pub-id pub-id-type="pmid">21042548</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S13662</pub-id><pub-id pub-id-type="pmcid">PMC2963932</pub-id></mixed-citation></ref><ref id="os70149-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="os70149-cit-0039"><string-name name-style="western"><given-names>J. A.</given-names><surname>Gaasch</surname></string-name>, <string-name name-style="western"><given-names>P. R.</given-names><surname>Lockman</surname></string-name>, <string-name name-style="western"><given-names>W. J.</given-names><surname>Geldenhuys</surname></string-name>, <string-name name-style="western"><given-names>D. D.</given-names><surname>Allen</surname></string-name>, and <string-name name-style="western"><given-names>C. J.</given-names><surname>Van der Schyf</surname></string-name>, &#8220;<article-title>Brain Iron Toxicity: Differential Responses of Astrocytes, Neurons, and Endothelial Cells</article-title>,&#8221; <source>Neurochemical Research</source><volume>32</volume>, no. <issue>7</issue> (<year>2007</year>): <fpage>1196</fpage>&#8211;<lpage>1208</lpage>.<pub-id pub-id-type="pmid">17404839</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11064-007-9290-4</pub-id></mixed-citation></ref><ref id="os70149-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="os70149-cit-0040"><string-name name-style="western"><given-names>J.</given-names><surname>Xiong</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Wu</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Chen</surname></string-name>, et&#160;al., &#8220;<article-title>Cancer&#8208;Erythrocyte Hybrid Membrane&#8208;Camouflaged Magnetic Nanoparticles With Enhanced Photothermal&#8208;Immunotherapy for Ovarian Cancer</article-title>,&#8221; <source>ACS Nano</source><volume>15</volume>, no. <issue>12</issue> (<year>2021</year>): <fpage>19756</fpage>&#8211;<lpage>19770</lpage>.<pub-id pub-id-type="pmid">34860006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsnano.1c07180</pub-id></mixed-citation></ref><ref id="os70149-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="os70149-cit-0041"><string-name name-style="western"><given-names>M. J.</given-names><surname>Thrippleton</surname></string-name>, <string-name name-style="western"><given-names>G. W.</given-names><surname>Blair</surname></string-name>, <string-name name-style="western"><given-names>M. C.</given-names><surname>Valdes&#8208;Hernandez</surname></string-name>, et&#160;al., &#8220;<article-title>MRI Relaxometry for Quantitative Analysis of USPIO Uptake in Cerebral Small Vessel Disease</article-title>,&#8221; <source>International Journal of Molecular Sciences</source><volume>20</volume>, no. <issue>3</issue> (<year>2019</year>): <fpage>776</fpage>.<pub-id pub-id-type="pmid">30759756</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms20030776</pub-id><pub-id pub-id-type="pmcid">PMC6387454</pub-id></mixed-citation></ref><ref id="os70149-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="os70149-cit-0042"><string-name name-style="western"><given-names>J. A.</given-names><surname>Mintarjo</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Poerwanto</surname></string-name>, and <string-name name-style="western"><given-names>E. H.</given-names><surname>Tedyanto</surname></string-name>, &#8220;<article-title>Current Non&#8208;Surgical Management of Knee Osteoarthritis</article-title>,&#8221; <source>Cureus</source><volume>15</volume>, no. <issue>6</issue> (<year>2023</year>): <elocation-id>e40966</elocation-id>.<pub-id pub-id-type="pmid">37503484</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.40966</pub-id><pub-id pub-id-type="pmcid">PMC10370281</pub-id></mixed-citation></ref><ref id="os70149-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="os70149-cit-0043"><string-name name-style="western"><given-names>Z.</given-names><surname>Yuan</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Jiang</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Yang</surname></string-name>, et&#160;al., &#8220;<article-title>Emerging Roles of Macrophage Polarization in Osteoarthritis: Mechanisms and Therapeutic Strategies</article-title>,&#8221; <source>Orthopaedic Surgery</source><volume>16</volume>, no. <issue>3</issue> (<year>2024</year>): <fpage>532</fpage>&#8211;<lpage>550</lpage>.<pub-id pub-id-type="pmid">38296798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/os.13993</pub-id><pub-id pub-id-type="pmcid">PMC10925521</pub-id></mixed-citation></ref><ref id="os70149-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="os70149-cit-0044"><string-name name-style="western"><given-names>F.</given-names><surname>Mohammad</surname></string-name> and <string-name name-style="western"><given-names>N. A.</given-names><surname>Yusof</surname></string-name>, &#8220;<article-title>Doxorubicin&#8208;Loaded Magnetic Gold Nanoshells for a Combination Therapy of Hyperthermia and Drug Delivery</article-title>,&#8221; <source>Journal of Colloid and Interface Science</source><volume>434</volume> (<year>2014</year>): <fpage>89</fpage>&#8211;<lpage>97</lpage>.<pub-id pub-id-type="pmid">25170601</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcis.2014.07.025</pub-id></mixed-citation></ref><ref id="os70149-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="os70149-cit-0045"><string-name name-style="western"><given-names>S.</given-names><surname>Liu</surname></string-name>, <string-name name-style="western"><given-names>Y.</given-names><surname>Chai</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Linghu</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Zhang</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Chai</surname></string-name>, and <string-name name-style="western"><given-names>Y.</given-names><surname>Lv</surname></string-name>, &#8220;<article-title>Magnetic Multidirectional Anchor&#8208;Guided Endoscopic Submucosal Tunnel Dissection for Large Gastric Lesions</article-title>,&#8221; <source>Endoscopy</source><volume>53</volume>, no. <issue>10</issue> (<year>2021</year>): <fpage>E382</fpage>&#8211;<lpage>E383</lpage>.<pub-id pub-id-type="pmid">33296921</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/a-1298-3984</pub-id></mixed-citation></ref><ref id="os70149-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="os70149-cit-0046"><string-name name-style="western"><given-names>S.</given-names><surname>Zheng</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Han</surname></string-name>, <string-name name-style="western"><given-names>Z.</given-names><surname>Jin</surname></string-name>, et&#160;al., &#8220;<article-title>Dual Tumor&#8208;Targeted Multifunctional Magnetic Hyaluronic Acid Micelles for Enhanced MR Imaging and Combined Photothermal&#8208;Chemotherapy</article-title>,&#8221; <source>Colloids and Surfaces B: Biointerfaces</source><volume>164</volume> (<year>2018</year>): <fpage>424</fpage>&#8211;<lpage>435</lpage>.<pub-id pub-id-type="pmid">29433060</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.colsurfb.2018.02.005</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>